89 related articles for article (PubMed ID: 21190859)
1. Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists.
Haga Y; Mizutani S; Naya A; Kishino H; Iwaasa H; Ito M; Ito J; Moriya M; Sato N; Takenaga N; Ishihara A; Tokita S; Kanatani A; Ohtake N
Bioorg Med Chem; 2011 Jan; 19(2):883-93. PubMed ID: 21190859
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
[TBL] [Abstract][Full Text] [Related]
4. Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists.
Kishino H; Moriya M; Sakuraba S; Sakamoto T; Takahashi H; Suzuki T; Moriya R; Ito M; Iwaasa H; Takenaga N; Ishihara A; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Aug; 19(16):4589-93. PubMed ID: 19615899
[TBL] [Abstract][Full Text] [Related]
5. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists.
Guo T; Gu H; Hobbs DW; Busler DE; Rokosz LL
Bioorg Med Chem Lett; 2007 Mar; 17(6):1718-21. PubMed ID: 17251014
[TBL] [Abstract][Full Text] [Related]
6. Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases.
Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar BD; Weig B
Bioorg Med Chem Lett; 2006 Oct; 16(20):5427-31. PubMed ID: 16889961
[TBL] [Abstract][Full Text] [Related]
7. Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis.
Guo T; Hunter RC; Gu H; Rokosz LL; Stauffer TM; Hobbs DW
Bioorg Med Chem Lett; 2005 Aug; 15(16):3691-5. PubMed ID: 15953726
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
[TBL] [Abstract][Full Text] [Related]
9. 4-Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1R) antagonists.
Jiang J; Lin P; Hoang M; Chang L; Tan C; Feighner S; Palyha OC; Hreniuk DL; Pan J; Sailer AW; Morin NR; MacNeil DJ; Howard AD; Van der Ploeg LH; Goulet MT; DeVita RJ
Bioorg Med Chem Lett; 2006 Oct; 16(20):5275-9. PubMed ID: 16919453
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1.
Souers AJ; Wodka D; Gao J; Lewis JC; Vasudevan A; Gentles R; Brodjian S; Dayton B; Ogiela CA; Fry D; Hernandez LE; Marsh KC; Collins CA; Kym PR
Bioorg Med Chem Lett; 2004 Oct; 14(19):4873-7. PubMed ID: 15341942
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists.
Troxler T; Hurth K; Mattes H; Prashad M; Schoeffter P; Langenegger D; Enz A; Hoyer D
Bioorg Med Chem Lett; 2009 Mar; 19(5):1305-9. PubMed ID: 19208473
[TBL] [Abstract][Full Text] [Related]
12. Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists.
Troxler T; Hurth K; Schuh KH; Schoeffter P; Langenegger D; Enz A; Hoyer D
Bioorg Med Chem Lett; 2010 Mar; 20(5):1728-34. PubMed ID: 20137944
[TBL] [Abstract][Full Text] [Related]
13. Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
Nakamura M; Kurihara H; Suzuki G; Mitsuya M; Ohkubo M; Ohta H
Bioorg Med Chem Lett; 2010 Jan; 20(2):726-9. PubMed ID: 20005101
[TBL] [Abstract][Full Text] [Related]
14. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
[TBL] [Abstract][Full Text] [Related]
15. 3-Urea-1-(phenylmethyl)-pyridones as novel, potent, and selective EP3 receptor antagonists.
Li YH; Tseng PS; Evans KA; Jaworski JP; Morrow DM; Fries HE; Wu CW; Edwards RM; Jin J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6744-7. PubMed ID: 20926294
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: a novel class of potent MCH-R1 antagonists.
Méndez-Andino JL; Colson AO; Meyers KM; Mitchell MC; Hodge K; Howard JM; Kim N; Ackley DC; Holbert JK; Mittelstadt SW; Dowty ME; Obringer CM; Suchanek P; Reizes O; Hu XE; Wos JA
Bioorg Med Chem; 2007 Mar; 15(5):2092-105. PubMed ID: 17236777
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists.
Morales-Ramos ÁI; Li YH; Hilfiker M; Mecom JS; Eidam P; Shi D; Tseng PS; Brooks C; Zhang D; Wang N; Jaworski JP; Morrow D; Fries H; Edwards R; Jin J
Bioorg Med Chem Lett; 2011 May; 21(10):2806-11. PubMed ID: 21514150
[TBL] [Abstract][Full Text] [Related]
18. The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to lead.
Siu T; Kozina ES; Jung J; Rosenstein C; Mathur A; Altman MD; Chan G; Xu L; Bachman E; Mo JR; Bouthillette M; Rush T; Dinsmore CJ; Marshall CG; Young JR
Bioorg Med Chem Lett; 2010 Dec; 20(24):7421-5. PubMed ID: 21044843
[TBL] [Abstract][Full Text] [Related]
19. Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
Selness SR; Devraj RV; Monahan JB; Boehm TL; Walker JK; Devadas B; Durley RC; Kurumbail R; Shieh H; Xing L; Hepperle M; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R
Bioorg Med Chem Lett; 2009 Oct; 19(20):5851-6. PubMed ID: 19751974
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
